Native and genetically engineered anti-disialoganglioside monoclonal antibody treatment of melanoma

Cancer Chemother Biol Response Modif. 2005:22:789-97. doi: 10.1016/s0921-4410(04)22037-3.
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Neoplasm / immunology
  • Gangliosides / immunology*
  • Humans
  • Interleukin-2 / therapeutic use
  • Melanoma / drug therapy*
  • Melanoma / immunology*
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / immunology

Substances

  • Antibodies, Monoclonal
  • Antibodies, Neoplasm
  • Gangliosides
  • Interleukin-2
  • sialogangliosides